查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1767670

氯沙坦市場按適應症、強度、產品類型、年齡層、性別、分銷管道、形式、供應源和地區分類

Losartan Market, By indication, By Strength, By Product Type, By Age Group, By Gender, By Distribution Channel, By Form, By Source, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

氯沙坦市場預計將在 2025 年達到 16.8 億美元，在 2032 年將達到 22.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 4.1%。

分析範圍 分析詳細資訊
基準年 2024 市場規模（2025年） 16.8億美元
效能數據 2020-2024 預測期 2025-2032
預測期內的複合年成長率（2025-2032） 4.10% 預計金額（2032年） 22.3億美元

近年來，受全球高血壓和心血管疾病盛行率上升的推動，全球氯沙坦市場經歷了顯著成長。氯沙坦是血管收縮素II受體拮抗劑，被廣泛用於治療高血壓、心臟衰竭和糖尿病腎臟病。人們對不健康生活方式和有效血壓管理重要性的認知不斷提高，進一步推動了氯沙坦市場的擴張。此外，氯沙坦學名藥的供應日益充足且價格更加親民，也促進了其受歡迎程度的提升。隨著對高效抗高血壓藥物需求的不斷成長，預計未來幾年全球氯沙坦市場將大幅成長。

市場動態

全球氯沙坦市場受到多種關鍵促進因素、市場限制因素和機會的影響。市場成長的主要驅動力是高血壓及相關心血管疾病（如心臟衰竭和中風）的盛行率不斷上升。久坐不動、肥胖和高壓力水平等不健康的生活方式導致高血壓發病率顯著上升。此外，人們越來越意識到有效的血壓管理的重要性，以及價格合理的學名藥的供應，正在推動市場成長。然而，市場上也存在一些限制因素，例如替代抗高血壓藥物的存在以及使用氯沙坦的潛在副作用。此外，品牌氯沙坦產品的專利到期可能會加劇來自非專利製造商的競爭，從而影響主要參與者的市場佔有率。儘管面臨這些挑戰，市場仍呈現出有希望的成長機會，例如開發新型藥物輸送系統、擴大氯沙坦的治療應用以及高血壓高盛行率的新興經濟體中尚未開發的潛力。此外，製藥公司之間的策略聯盟和合併預計將在未來幾年推動創新並擴大市場範圍。

本報告的主要特點

  • 本報告對全球氯沙坦市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
  • 它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球氯沙坦市場的主要企業簡介是根據公司概況、產品系列、主要亮點、財務表現和策略等參數進行的。
  • 透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
  • 「全球氯沙坦市場」報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過用於分析全球氯沙坦市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 分析目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 驅動程式
  • 限制因素
  • 機會
  • 影響分析
  • 主要進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景
  • 產業趨勢
  • 治療方案分析
  • 抗藥性情景
  • 贖回方案
  • 監管情景

4. 全球氯沙坦市場（依適應症分類） (2020-2032)

  • 高血壓
  • 左心室肥大（LVH）
  • 糖尿病腎臟病
  • 其他（中風等）

5. 全球氯沙坦市場實力（2020-2032）

  • 5mg
  • 25mg
  • 50mg
  • 100mg

6. 全球氯沙坦市場依產品類型（2020-2032）

  • 品牌
  • 非專利的

7. 按年齡層別分類的全球氯沙坦市場（2020-2032 年）

  • 孩子們
  • 成人
  • 老年人

8. 全球氯沙坦市場（依性別分類）（2020-2032 年）

  • 男性
  • 女士

9. 全球氯沙坦市場按分銷管道分類（2020-2032 年）

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 10 章 全球氯沙坦市場（依形式）（2020-2032）

  • 錠劑
  • 粉末
  • 暫停

第 11 章 全球氯沙坦市場依來源分類（2020-2032）

  • 契約製造組織
  • 內部製造

第 12 章 按地區分類的全球氯沙坦市場（2020-2032 年）

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第13章競爭格局

  • Teva Pharmaceutical Industries Ltd
  • Mylan NV
  • Organon LLC
  • Alembic Pharmaceuticals Ltd
  • Macleods Pharmaceuticals Ltd
  • Teva Pharmaceuticals Usa
  • Aurobindo Pharma
  • Lupin Limited
  • Reddy's Laboratories
  • Sun Pharmaceutical Industries Ltd
  • Zydus Cadila
  • Torrent Pharmaceuticals Ltd
  • Cipla Ltd
  • Glenmark Pharmaceuticals
  • Alkem Laboratories
  • Granules India Ltd
  • Micro Labs Ltd

第14章 分析師建議

  • “命運之輪”
  • 分析師觀點
  • Coherent Opportunity Map (COM)

第15章參考文獻與調查方法

  • 參考
  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI8135

Losartan Market is estimated to be valued at USD 1.68 Bn in 2025 and is expected to reach USD 2.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.68 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.10% 2032 Value Projection: USD 2.23 Bn

The global Losartan market has witnessed significant growth in recent years, driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Losartan, an angiotensin II receptor antagonist, is widely prescribed for the treatment of high blood pressure, heart failure, and diabetic nephropathy. The market's expansion is further fueled by unhealthy lifestyles and rising awareness about the importance of effective blood pressure management. Moreover, the availability of generic Losartan products has increased their accessibility and affordability, contributing to their widespread adoption. As the demand for efficient antihypertensive medications continues to rise, the global Losartan market is poised for substantial growth in the coming years.

Market Dynamics

The global Losartan market is influenced by several key drivers, restraints, and opportunities. The primary driver for market growth is the increasing prevalence of hypertension and related cardiovascular disorders, such as heart failure and stroke. Unhealthy lifestyles characterized by sedentary behavior, obesity, and high-stress levels have led to a significant increase in the incidence of hypertension. Furthermore, the growing awareness about the importance of effective blood pressure management and the availability of affordable generic Losartan products have boosted the market's growth. However, the market also faces certain restraints, such as the presence of alternative antihypertensive medications and potential side effects associated with Losartan use. Additionally, the expiration of patents for branded Losartan products has led to increased competition from generic manufacturers, potentially impacting the market share of key players. Despite these challenges, the market presents promising opportunities for growth, including the development of novel drug delivery systems, the expansion of Losartan's therapeutic applications, and the untapped potential in emerging economies with high hypertension prevalence rates. Moreover, strategic collaborations and mergers among pharmaceutical companies are expected to drive innovation and expand market reach in the coming years.

Key features of the study

  • This report provides an in-depth analysis of the global Losartan market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global Losartan market based on the following parameters: company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, Mylan N.V., Organon LLC, Alembic Pharmaceuticals Ltd, Macleods Pharmaceuticals Ltd, Teva Pharmaceuticals Usa, Aurobindo Pharma, Lupin Limited, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Torrent Pharmaceuticals Ltd, Cipla Ltd, Glenmark Pharmaceuticals, Alkem Laboratories, Granules India Ltd, and Micro Labs Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global Losartan market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Losartan market.

Market Segmentation

  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Hypertension
    • Left Ventricular Hypertrophy (LVH)
    • Diabetic Nephropathy
    • Others (Stroke, etc.)
  • Strength Insights (Revenue, USD Bn, 2020 - 2032)
    • 5 mg
    • 25 mg
    • 50 mg
    • 100 mg
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Branded
    • Generic
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Pediatric
    • Adult
    • Geriatric
  • Gender Insights (Revenue, USD Bn, 2020 - 2032)
    • Male
    • Female
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Form Insights (Revenue, USD Bn, 2020 - 2032)
    • Tablet
    • Powder
    • Suspension
  • Source Insights (Revenue, USD Bn, 2020 - 2032)
    • Contract Manufacturing Organizations
    • In-House Manufacturing
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U,S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Teva Pharmaceutical Industries Ltd
    • Mylan N.V.
    • Organon LLC
    • Alembic Pharmaceuticals Ltd
    • Macleods Pharmaceuticals Ltd
    • Teva Pharmaceuticals USA
    • Aurobindo Pharma
    • Lupin Limited
    • Reddy's Laboratories
    • Sun Pharmaceutical Industries Ltd
    • Zydus Cadila
    • Torrent Pharmaceuticals Ltd
    • Cipla Ltd
    • Glenmark Pharmaceuticals
    • Alkem Laboratories
    • Granules India Ltd
    • Micro Labs Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Losartan Market, By Indication
    • Global Losartan Market, By Strength
    • Global Losartan Market, By Product Type
    • Global Losartan Market, By Age Group
    • Global Losartan Market, By Gender
    • Global Losartan Market, By Distribution Channel
    • Global Losartan Market, By Form
    • Global Losartan Market, By Source
    • Global Losartan Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends
  • Treatment Option Analysis
  • Drug Resistance Scenario
  • Reimbursement Scenario
  • Regulatory Scenario

4. Global Losartan Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Left Ventricular Hypertrophy (LVH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diabetic Nephropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Stroke, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Losartan Market, By Strength, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 5 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 25 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 50 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 100 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Losartan Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Losartan Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Losartan Market, By Gender, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Male
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Female
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Losartan Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Losartan Market, By Form, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Powder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Losartan Market, By Source, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Contract Manufacturing Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • In-House Manufacturing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Losartan Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

13. Competitive Landscape

  • Teva Pharmaceutical Industries Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organon LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alembic Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Macleods Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceuticals Usa
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aurobindo Pharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lupin Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reddy's Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zydus Cadila
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Torrent Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cipla Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Glenmark Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alkem Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Granules India Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Micro Labs Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

14. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

15. References and Research Methodology

  • References
  • Research Methodology
  • About us